Literature DB >> 10318670

beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart.

M Kuschel1, Y Y Zhou, H A Spurgeon, S Bartel, P Karczewski, S J Zhang, E G Krause, E G Lakatta, R P Xiao.   

Abstract

BACKGROUND: Recent studies of beta-adrenergic receptor (beta-AR) subtype signaling in in vitro preparations have raised doubts as to whether the cAMP/protein kinase A (PKA) signaling is activated in the same manner in response to beta2-AR versus beta1-AR stimulation. METHODS AND
RESULTS: The present study compared, in the intact dog, the magnitude and characteristics of chronotropic, inotropic, and lusitropic effects of cAMP accumulation, PKA activation, and PKA-dependent phosphorylation of key effector proteins in response to beta-AR subtype stimulation. In addition, many of these parameters and L-type Ca2+ current (ICa) were also measured in single canine ventricular myocytes. The results indicate that although the cAMP/PKA-dependent phosphorylation cascade activated by beta1-AR stimulation could explain the resultant modulation of cardiac function, substantial beta2-AR-mediated chronotropic, inotropic, and lusitropic responses occurred in the absence of PKA activation and phosphorylation of nonsarcolemmal proteins, including phospholamban, troponin I, C protein, and glycogen phosphorylase kinase. However, in single canine myocytes, we found that beta2-AR-stimulated increases in both ICa and contraction were abolished by PKA inhibition. Thus, the beta2-AR-directed cAMP/PKA signaling modulates sarcolemmal L-type Ca2+ channels but does not regulate PKA-dependent phosphorylation of cytoplasmic proteins.
CONCLUSIONS: These results indicate that the dissociation of beta2-AR signaling from cAMP regulatory systems is only apparent and that beta2-AR-stimulated cAMP/PKA signaling is uncoupled from phosphorylation of nonsarcolemmal regulatory proteins involved in excitation-contraction coupling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10318670     DOI: 10.1161/01.cir.99.18.2458

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  30 in total

1.  G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels.

Authors:  Y Chen-Izu; R P Xiao; L T Izu; H Cheng; M Kuschel; H Spurgeon; E G Lakatta
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Functional antagonism of β-adrenoceptor subtypes in the catecholamine-induced automatism in rat myocardium.

Authors:  D C Boer; J W M Bassani; R A Bassani
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 3.  Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes.

Authors:  Jabe M Best; Timothy J Kamp
Journal:  J Mol Cell Cardiol       Date:  2011-08-23       Impact factor: 5.000

4.  Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes.

Authors:  Ferenc Ruzsnavszky; Bence Hegyi; Kornél Kistamás; Krisztina Váczi; Balázs Horváth; Norbert Szentandrássy; Tamás Bányász; Péter P Nánási; János Magyar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-25       Impact factor: 3.000

5.  Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze.

Authors:  Vijay Sharma; John H McNeill
Journal:  World J Cardiol       Date:  2011-09-26

6.  Constitutive beta2-adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart.

Authors:  Y Y Zhou; L S Song; E G Lakatta; R P Xiao; H Cheng
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

Review 7.  Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.

Authors:  Anthony Yiu-Ho Woo; Ying Song; Rui-Ping Xiao; Weizhong Zhu
Journal:  Br J Pharmacol       Date:  2014-12-17       Impact factor: 8.739

Review 8.  cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies.

Authors:  Manuela Zaccolo
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

9.  Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.

Authors:  Torsten Christ; Alejandro Galindo-Tovar; Marcus Thoms; Ursula Ravens; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

10.  Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Emanuele Barbato; Martin Penicka; Leen Delrue; Frederic Van Durme; Bernard De Bruyne; Marc Goethals; William Wijns; Marc Vanderheyden; Jozef Bartunek
Journal:  Heart       Date:  2007-07       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.